Q2 2021 Holdings
Filed 2021-08-11 | 34 holdings | $252.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $230.2M | 8,434,232 | 91.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $15.2M | 2,283,966 | 6.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $6.5M | 370,733 | 2.6% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $197.3K | 5,827,415 | 0.1% |
| Passage BIO Inc | COM | 702712100 | $66.3K | 5,009,219 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $61.7K | 3,566,912 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $57.4K | 2,082,789 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $55.6K | 2,137,999 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $53.6K | 787,876 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $52.0K | 2,309,554 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $41.1K | 1,417,157 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $30.3K | 3,123,107 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $23.3K | 899,700 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $23.1K | 2,571,450 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $20.4K | 1,188,135 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $18.6K | 1,001,421 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $16.1K | 2,544,500 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $15.5K | 1,100,000 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $15.1K | 1,501,000 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $13.7K | 351,954 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $10.7K | 1,374,047 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $9.4K | 1,030,878 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $9.0K | 316,616 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $6.1K | 739,369 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $5.3K | 1,883,244 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.5K | 156,000 | 0.0% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $4.5K | 550,000 | 0.0% |
| Allena Pharmaceuticals(ALNAEUR) | COM | 018119107 | $4.3K | 3,330,373 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.0K | 1,296,743 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.9K | 202,803 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $3.9K | 578,104 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.7K | 254,000 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $2.4K | 241,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637113 | $575 | 425,650 | 0.0% |